Header Logo

Connection

MARIA REDONDO to Adolescent

Back to Details
This is a "connection" page, showing publications MARIA REDONDO has written about Adolescent.
MARIA REDONDO
Connection Strength
1.998
Adolescent
  1. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
    View in: PubMed
    Score: 0.064
  2. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2025 Mar; 68(3):588-601.
    View in: PubMed
    Score: 0.063
  3. Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2025 Jan 29; 38(1):22-28.
    View in: PubMed
    Score: 0.062
  4. Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic. J Pediatr Endocrinol Metab. 2024 Sep 25; 37(9):759-763.
    View in: PubMed
    Score: 0.061
  5. Inaccurate diagnosis of diabetes type in youth: prevalence, characteristics, and implications. Sci Rep. 2024 04 17; 14(1):8876.
    View in: PubMed
    Score: 0.060
  6. Elevated Serum IgA at Onset of Type 1 Diabetes in Children. Pediatr Diabetes. 2024; 2024:7284088.
    View in: PubMed
    Score: 0.059
  7. Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes Metab Res Rev. 2024 Mar; 40(3):e3744.
    View in: PubMed
    Score: 0.058
  8. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obes Metab. 2023 11; 25(11):3420-3423.
    View in: PubMed
    Score: 0.057
  9. Clinical Characterization of Data-Driven Diabetes Clusters of Pediatric Type 2 Diabetes. Pediatr Diabetes. 2023; 2023.
    View in: PubMed
    Score: 0.057
  10. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. 2023 01; 66(1):127-131.
    View in: PubMed
    Score: 0.054
  11. Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children. Annu Rev Med. 2022 01 27; 73:501-515.
    View in: PubMed
    Score: 0.051
  12. Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
    View in: PubMed
    Score: 0.050
  13. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.049
  14. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes. Pediatr Diabetes. 2021 09; 22(6):882-888.
    View in: PubMed
    Score: 0.049
  15. Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia. 2021 04; 64(4):836-844.
    View in: PubMed
    Score: 0.048
  16. The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence. Diabetes Care. 2021 02; 44(2):301-312.
    View in: PubMed
    Score: 0.048
  17. Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes. BMJ Open Diabetes Res Care. 2020 10; 8(1).
    View in: PubMed
    Score: 0.047
  18. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance. J Clin Endocrinol Metab. 2020 05 01; 105(5).
    View in: PubMed
    Score: 0.045
  19. Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2018 12; 41(12):2480-2486.
    View in: PubMed
    Score: 0.041
  20. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018 09; 41(9):1887-1894.
    View in: PubMed
    Score: 0.040
  21. Response to Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024. Diabetes Care. 2018 07; 41(7):e125-e126.
    View in: PubMed
    Score: 0.040
  22. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.039
  23. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2018 02; 41(2):311-317.
    View in: PubMed
    Score: 0.038
  24. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes. Diabet Med. 2017 10; 34(10):1435-1439.
    View in: PubMed
    Score: 0.037
  25. Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes. Diabet Med. 2017 02; 34(2):286-290.
    View in: PubMed
    Score: 0.034
  26. Psychosocial aspects of type 1 diabetes in Latino- and Asian-American youth. Pediatr Res. 2016 09; 80(3):347-55.
    View in: PubMed
    Score: 0.034
  27. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes. Diabet Med. 2017 05; 34(5):641-646.
    View in: PubMed
    Score: 0.034
  28. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 2016 Apr; 53(2):271-7.
    View in: PubMed
    Score: 0.032
  29. Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2014 Dec; 15(8):543-9.
    View in: PubMed
    Score: 0.030
  30. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):294-302.
    View in: PubMed
    Score: 0.028
  31. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes. 2013 Aug; 14(5):333-40.
    View in: PubMed
    Score: 0.028
  32. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 2008 Dec 25; 359(26):2849-50.
    View in: PubMed
    Score: 0.021
  33. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab. 2006 May; 91(5):1705-13.
    View in: PubMed
    Score: 0.017
  34. Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval. Diabetes. 2025 Nov 01; 74(11):2101-2110.
    View in: PubMed
    Score: 0.017
  35. Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study. Diabetes Care. 2025 Sep 01; 48(9):1571-1580.
    View in: PubMed
    Score: 0.016
  36. Development and recalibration?of a?multivariable?type 1 diabetes prediction model for?type 1 diabetes across multiple screening studies. BMC Med. 2025 Jul 21; 23(1):433.
    View in: PubMed
    Score: 0.016
  37. The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes. 2025 Jul 01; 74(7):1196-1204.
    View in: PubMed
    Score: 0.016
  38. The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth. J Clin Endocrinol Metab. 2025 Jun 17; 110(7):e2191-e2197.
    View in: PubMed
    Score: 0.016
  39. Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter. Diabetologia. 2025 Aug; 68(8):1709-1720.
    View in: PubMed
    Score: 0.016
  40. IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 2025 May; 68(5):993-1004.
    View in: PubMed
    Score: 0.016
  41. A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 Mar; 27(3):179-186.
    View in: PubMed
    Score: 0.016
  42. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
    View in: PubMed
    Score: 0.016
  43. Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2024 Dec 01; 47(12):2110-2119.
    View in: PubMed
    Score: 0.016
  44. Identification of atypical pediatric diabetes mellitus cases using electronic medical records. BMJ Open Diabetes Res Care. 2024 Nov 07; 12(6).
    View in: PubMed
    Score: 0.016
  45. Random C-Peptide and Islet Antibodies at Onset Predict ? Cell Function Trajectory and Insulin Dependence in Pediatric Diabetes. Endocr Pract. 2024 Dec; 30(12):1149-1157.
    View in: PubMed
    Score: 0.015
  46. Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes. Pediatr Diabetes. 2024; 2024:8343868.
    View in: PubMed
    Score: 0.015
  47. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis. Diabetologia. 2024 Nov; 67(11):2507-2517.
    View in: PubMed
    Score: 0.015
  48. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes Care. 2024 Jun 01; 47(6):1048-1055.
    View in: PubMed
    Score: 0.015
  49. Variants of Unknown Significance in Maturity-Onset Diabetes of the Young: High Rate of Conundrum Resolution via Variants of Unknown Significance Reanalysis. Horm Res Paediatr. 2025; 98(5):524-531.
    View in: PubMed
    Score: 0.015
  50. High Prevalence of A-?+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
    View in: PubMed
    Score: 0.015
  51. Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
    View in: PubMed
    Score: 0.014
  52. Plasma amino acid signatures define types of pediatric diabetes. Clin Nutr ESPEN. 2023 10; 57:21-28.
    View in: PubMed
    Score: 0.014
  53. Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth. Diabetes Care. 2022 05 01; 45(5):1124-1131.
    View in: PubMed
    Score: 0.013
  54. Optimizing maturity-onset diabetes of the young detection in a pediatric diabetes population. Pediatr Diabetes. 2022 06; 23(4):447-456.
    View in: PubMed
    Score: 0.013
  55. Exome sequencing in children with clinically suspected maturity-onset diabetes of the young. Pediatr Diabetes. 2021 11; 22(7):960-968.
    View in: PubMed
    Score: 0.012
  56. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. 2021 10; 44(10):2329-2336.
    View in: PubMed
    Score: 0.012
  57. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar; 44(3):354-62.
    View in: PubMed
    Score: 0.012
  58. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.012
  59. Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals. Diabetes Obes Metab. 2020 06; 22(6):997-1000.
    View in: PubMed
    Score: 0.011
  60. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents. Diabetes Care. 2020 03; 43(3):580-587.
    View in: PubMed
    Score: 0.011
  61. Using Relational Agents to Promote Family Communication Around Type 1 Diabetes Self-Management in the Diabetes Family Teamwork Online Intervention: Longitudinal Pilot Study. J Med Internet Res. 2019 09 13; 21(9):e15318.
    View in: PubMed
    Score: 0.011
  62. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ. 1999 Mar 13; 318(7185):698-702.
    View in: PubMed
    Score: 0.010
  63. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk. Diabetologia. 2018 09; 61(9):2043-2053.
    View in: PubMed
    Score: 0.010
  64. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry. Pediatr Diabetes. 2018 06; 19(4):741-748.
    View in: PubMed
    Score: 0.010
  65. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab. 2017 08 01; 102(8):2873-2880.
    View in: PubMed
    Score: 0.009
  66. Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development? Diabetes Care. 2017 05; 40(5):698-701.
    View in: PubMed
    Score: 0.009
  67. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2017 Nov; 18(7):566-573.
    View in: PubMed
    Score: 0.009
  68. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.008
  69. Body mass index changes in youth in the first year after type 1 diabetes diagnosis. J Pediatr. 2015 May; 166(5):1265-1269.e1.
    View in: PubMed
    Score: 0.008
  70. An unknown risk group of lead poisoning: the gypsy children. Eur J Pediatr. 1995 Mar; 154(3):197-200.
    View in: PubMed
    Score: 0.008
  71. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):287-93.
    View in: PubMed
    Score: 0.007
  72. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):929-34.
    View in: PubMed
    Score: 0.007
  73. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr. 2013 Apr; 162(4):736-740.e1.
    View in: PubMed
    Score: 0.007
  74. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun. 2005; 25 Suppl:40-5.
    View in: PubMed
    Score: 0.004
  75. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes. 2005 Aug; 54(8):2482-6.
    View in: PubMed
    Score: 0.004
  76. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J. 2005 Jun; 7(6):381-4.
    View in: PubMed
    Score: 0.004
  77. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest. 2001 Mar; 107(5):555-64.
    View in: PubMed
    Score: 0.003
  78. Dual-parameter model for prediction of type I diabetes mellitus. Proc Assoc Am Physicians. 1998 Mar-Apr; 110(2):126-35.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.